Archive

Febrile neutropenia is common in patients with cancer; however, there is still debate on the most effective treatment for this adverse event.

Patient-reported outcome measures are emerging from the clinical trial settings, and are now having an impact on daily clinical practice.

Companion diagnostic devices are designed to identify the appropriate treatment for patients based on their targeted oncology agent counterparts.

Nanoparticle drug delivery may revolutionize the way patients with cancer receive treatment, but the technology is still in its infancy.

A follow-up study that investigates lifestyle habits and their correlation to cancer is underway.

Although rare, being diagnosed with cancer while pregnant can mean a new set of challenges for patients and their doctors.

There is doubt around whether statins can prevent some cancers, but there are data to support their effect on cancer mortality.

Recent news has brought attention to HPV and its connection to cancer, but there is still confusion about how and when the vaccine should be given.